NUCLERA
Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered to take control of biology through streamlined access to a next-day supply of proteins and genes.
NUCLERA
Industry:
Biotechnology Industrial Engineering Life Science Pharmaceutical
Founded:
2013-08-27
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.nuclera.com
Total Employee:
11+
Status:
Active
Total Funding:
69.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network ReCAPTCHA Cloudflare JS CDN JS COVID-19
Similar Organizations
Fluidic Analytics
Fluidic Analytics designs, develops and manufactures tools that seek to revolutionise the way proteins are characterised.
Holiferm
Holiferm develops holistically improved fermentation technology for massive economic improvements.
Onego Bio
Onego Bio is a smart protein is a piece of cake.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-12 | E Ink -Digital Microfluidics Business | E Ink -Digital Microfluidics Business acquired by Nuclera | N/A |
Investors List
Verve Ventures
Verve Ventures investment in Series B - Nuclera
Jonathan Milner
Jonathan Milner investment in Series B - Nuclera
G. K. Goh
G. K. Goh investment in Series B - Nuclera
Future Planet Capital
Future Planet Capital investment in Series B - Nuclera
Amadeus Capital Partners
Amadeus Capital Partners investment in Series B - Nuclera
British Business Bank
British Business Bank investment in Series B - Nuclera
RT Partners
RT Partners investment in Series B - Nuclera
M&G Investments
M&G Investments investment in Series B - Nuclera
E Ink
E Ink investment in Series B - Nuclera
Official Site Inspections
http://www.nuclera.com Semrush global rank: 3.36 M Semrush visits lastest month: 4.72 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nuclera"
Making Proteins Accessible | Nuclera
Get answers faster and power-up drug discovery workflows by screening and synthesizing proteins on your own terms, on your own bench. The only end-to-end protein prototyping …See details»
About us - Nuclera
Nuclera is the pioneer in bringing rapid protein prototyping to the benchtop. We make proteins accessible through eProtein Discovery TM. Through our technology, we accelerate breakthrough improvements in human health and …See details»
Protein Expression System | Nuclera
Aiming to get active proteins? Nuclera's rapid prototyping protein expression system empowers scientists to advance their protein projects. Click here.See details»
Nuclera - Crunchbase Company Profile & Funding
Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.See details»
Nuclera Ltd - Cambridge Judge Business School
Nuclera is a US and UK-based biotechnology company driven by the mission to better human health by making proteins accessible. Nuclera is enabling life science researchers to obtain …See details»
Nuclera - LinkedIn
At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow...See details»
Nuclera's CEO and Executive Team - Team members and …
The executive team at Nuclera has a wealth of experience in research and academia, as well as business and finance. The team is led by Dr. Sarah Hake, who has a Ph.D. in Chemistry from …See details»
Nuclera Company Profile 2024: Valuation, Funding
Developer of an automated construct platform designed to power up drug discovery workflows.See details»
Our Team - Nuclera
Nuclera is on a mission to better human health by making proteins accessible. Meet the people guiding our approach including our global leadership team, board members and scientific advisors.See details»
Nuclera | Lab Manager
Nuclera is the leading pioneer in making biology accessible through desktop enzymatic protein and gene synthesis. Headquartered in Cambridge, UK, Nuclera was founded in 2013 by four …See details»
Nuclera to scale in US and Europe after closing $75m …
Oct 16, 2024 · Cambridge life science rising star Nuclera is set to step up commercialisation worldwide – especially across the US and Europe – after closing a $75 million Series C round …See details»
Nuclera - LinkedIn
At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow...See details»
Nuclera announces key leadership appointments to drive …
In a move that signals a shift towards commercial growth and technological advancement, Cambridge-based biotechnology company Nuclera has announced significant changes to its …See details»
Investors - Nuclera
Nuclera is the world leader in protein digital microfluidics, and our platform gives us unprecedented flexibility to develop automated workflows. We are always on the lookout for …See details»
Nuclera Secures US$75m to Advance Protein Discovery …
Oct 22, 2024 · Nuclera, a biotech company based in Cambridge, UK, has raised US$75m in a Series C funding round led by Elevage Medical Technologies, backed by Patient Square …See details»
Nuclera Company Profile - Office Locations, Competitors
Nuclera is a company that specializes in DNA synthesis. It develops a platform enabling the production of accurate, ultra-long DNA and genome libraries for protein, biological pathway, …See details»
Corporate Social Responsibility | Nuclera
We integrate social and environmental concerns within Nuclera's values. We believe that true advancement occurs when it can be shared by everyone. Our planet faces massive economic, …See details»
Nuclera - Overview, News & Similar companies
Apr 25, 2024 · View Nuclera (www.nuclera.com) location in Cambridgeshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees …See details»
News - Nuclera
Oct 16, 2024 · Nuclera partners with Sharp Life Science advancing its digital microfluidics capabilitySee details»